E80: Virtual Senior Centers, Honey Bee Vaccines, and Financial Crime Fighters

0 Views· 08/17/23
Venture Pill
Venture Pill
0 Subscribers
0

Our Social Media Pages, follow us and engage with the Pill-grim community!
Join our Entre CommunityInstagramTwitter YouTubeTikTokLinkedIn
And now for this week’s prescription:
On this week’s dose, (1:50) you will hear about Peppermint, a new online community for adults 55+, and their $8M seed round from Primetime Partners and Redesign Health. Next, (8:14) you’ll hear about Dalan Animal Health, the pioneering biotech company that recently raised a $4.5M Series Seed 3 led by Prime Movers Lab. The company developed and launched the world's first honeybee vaccine. Lastly, (13:45) stick with us for a breakdown on Resistant AI, a Prague-based startup that helps protect financial services firms from the evolving financial crime landscape. The company raised an $11M Series A extension from Notion Capital and has won b2b Digital Crime Fighter of the Year awards.
Sources:
https://www.businesswire.com/news/home/20230719845294/en/Peppermint-Launches-Groundbreaking-Online-Community-to-Promote-Peer-Connection-Engagement-Amongst-Adults-55https://join.mypeppermint.com/ https://www.businesswire.com/news/home/20230627720385/en/Bee-Vaccine-Pioneer-Dalan-Secures-4.5M-to-Fuel-Global-Expansion-and-Product-Developmenthttps://finance.yahoo.com/news/bee-vaccine-pioneer-dalan-secures-130000686.htmlhttps://www.dalan.com/https://resistant.ai/news/resistant-ai-extends-series-a-to-27.6mhttps://news.fintech.io/post/102ii3v/resistant-ai-raises-11m-in-series-a-extension-funding
Music Credit: Chapter One by Cole Bauer and Dean Keeton
https://www.colebauer.com/https://www.instagram.com/deankeeton/?hl=en
Disclosure:
The views, statements, and opinions, expressed herein by the hosts and guests are their own, and their appearance on the podcast should not be construed as reflecting the views or implied endorsement of Independent Brokerage Solutions LLC or any of its officers, employees, or agents. The statements made herein should not be considered an investment opinion, advice, or a recommendation regarding securities of any company. This podcast is produced solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy a security.

Show more

 0 Comments sort   Sort By


Up next